Horses with recurrent airway obstruction may no longer have to suffer following Food and Drug Administration approval of a specially designed equine inhaler with medication.
Horses with recurrent airway obstruction may no longer have to suffer following Food and Drug Administration approval of a specially designed equine inhaler with medication.
Boehringer-Ingelheim Vetmedica has received the approval for Torpex, which uses albuterol sulfate combined with an equine-specific metered dose inhaler developed by 3m.
The device is expected to be on the market later this spring.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More